| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.19 | 0.0005 |